Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
1.230
-0.030 (-2.38%)
Jan 29, 2026, 1:20 PM EST - Market open
Tivic Health Systems Revenue
Tivic Health Systems had revenue of $146.00K in the quarter ending September 30, 2025, with 15.87% growth. This brings the company's revenue in the last twelve months to $482.00K, down -49.63% year-over-year. In the year 2024, Tivic Health Systems had annual revenue of $780.00K, down -33.67%.
Revenue (ttm)
$482.00K
Revenue Growth
-49.63%
P/S Ratio
2.12
Revenue / Employee
$68,857
Employees
7
Market Cap
3.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 780.00K | -396.00K | -33.67% |
| Dec 31, 2023 | 1.18M | -664.00K | -36.09% |
| Dec 31, 2022 | 1.84M | 583.00K | 46.38% |
| Dec 31, 2021 | 1.26M | 397.00K | 46.16% |
| Dec 31, 2020 | 860.00K | 440.00K | 104.76% |
| Dec 31, 2019 | 420.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Venus Concept | 58.88M |
| STRATA Skin Sciences | 30.98M |
| WORK Medical Technology Group LTD | 10.74M |
| Nuwellis | 8.17M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| Catheter Precision | 730.00K |
TIVC News
- 1 day ago - Tivic, BARDA Discuss Entolimod(TM) for Acute Radiation Syndrome at TechWatch Meeting - Accesswire
- 3 days ago - Tivic to Showcase Strategic Pivot and Forward Outlook on Advancing Entolimod(TM) to Commercialization at DealFlow Discovery Conference - Accesswire
- 8 days ago - Tivic CEO To Present at the Upcoming Emerging Growth's January 2026 Virtual Conference - Accesswire
- 16 days ago - Tivic Health Systems, Inc. (TIVC) Discusses Acquisition of Biomanufacturing Assets and Strategic Transformation Transcript - Seeking Alpha
- 17 days ago - Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity - Accesswire
- 21 days ago - Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets - Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines - Accesswire
- 7 weeks ago - Tivic Acquires Ready-to-Scale cGMP Manufacturing and Development Assets to Accelerate Commercialization of Entolimod; Tivic Growth Backed By $90M+ Financing Package - Accesswire
- 2 months ago - Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome - Accesswire